Diabetes Research and Clinical Practice
Volume 88, Issue 2 , Pages e17-e19, May 2010

Glucose control in patients with type 2 diabetes based on frequency of insulin glargine administration

Veterans Affairs Medical Center, Iowa City, IA, USA

Received 30 June 2009; received in revised form 9 January 2010; accepted 18 January 2010. published online 08 February 2010.

Abstract 

Glucose control and predictors of a switch from once to twice daily administration of insulin glargine in patients with type 2 diabetes was investigated. A mean decrease in %A1c of 0.52±0.12 (p=0.14) resulted, indicating clinical relevance. Daily dose was the only significant predictor of twice daily therapy.

Keywords: Insulin glargine twice daily, Type 2 diabetes mellitus, Glucose control, Predictors

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8227(10)00043-4

doi:10.1016/j.diabres.2010.01.020

Diabetes Research and Clinical Practice
Volume 88, Issue 2 , Pages e17-e19, May 2010

Article Tools

* Image Usage & Resolution